BCL2 and neoplasm: Finally, further investigation of the signaling mechanisms by which auranofin downregulates the expression of antiapoptotic proteins IKK-β and Bcl-2 that in turn contributes to tumor cell survival/growth may provide new cellular targets that can be exploited therapeutically.